Honestly speaking, I think Morgans' report is a bit too bullish.
If the intention is to not pay out anything to shareholders in the foreseeable future, the NPV of the shares (to non-insiders without 'renovation' conpanies) is zero. They ascribe a few cents to the stock - very bullish in my view.
- Forums
- ASX - By Stock
- XPD
- Ann: Commentary on 2016 full year results
Ann: Commentary on 2016 full year results, page-65
Featured News
Add XPD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online